Literature DB >> 12685844

CD148 and CD27 are expressed in B cell lymphomas derived from both memory and naïve B cells.

Henry Y Dong1, Aliakbar Shahsafaei, David M Dorfman.   

Abstract

CD148 and CD27 are activation antigens involved in B cell and T cell activation and development. They have been recently proposed as markers of normal human memory B cells corresponding to the presence of somatically hypermutated IgV genes. We undertook an immunohistochemical study of CD148 and CD27 expression on neoplastic B cells in 116 cases of B cell non-Hodgkin's lymphoma. All cases of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), mantle cell lymphoma, Burkitt's lymphoma, and the vast majority of cases of marginal zone B cell lymphoma and most cases of plasmacytoma/myeloma expressed CD148 and CD27. Follicular lymphoma and diffuse large B cell lymphoma were also immunoreactive for CD148 and CD27 with some variation and discordance in expression. Cases of precursor B-lymphoblastic lymphoma/leukemia did not express CD148 or CD27. Our findings demonstrate that CD148 and CD27 are expressed in a wide range of B cell non-Hodgkin's lymphomas, and, therefore, do not serve to distinguish between neoplastic cells of naïve and memory B cell derivation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12685844     DOI: 10.1080/1042819021000006385

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  12 in total

1.  Safety and activity of varlilumab, a novel and first-in-class agonist anti-CD27 antibody, for hematologic malignancies.

Authors:  Stephen M Ansell; Ian Flinn; Matthew H Taylor; Branimir I Sikic; Joshua Brody; John Nemunaitis; Andrew Feldman; Thomas R Hawthorne; Tracey Rawls; Tibor Keler; Michael J Yellin
Journal:  Blood Adv       Date:  2020-05-12

2.  Sjögren's syndrome: an autoimmune disorder with otolaryngological involvement.

Authors:  M Tucci; C Quatraro; F Silvestris
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-06       Impact factor: 2.124

Review 3.  Immunoglobulin gene analysis of mature B-cell malignancies: reconsideration of cellular origin and potential antigen involvement in pathogenesis.

Authors:  Sarah H Walsh; Richard Rosenquist
Journal:  Med Oncol       Date:  2005       Impact factor: 3.064

4.  Antibodies against CD20 or B-cell receptor induce similar transcription patterns in human lymphoma cell lines.

Authors:  Andreas Franke; Gerhard J Niederfellner; Christian Klein; Helmut Burtscher
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

5.  Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma.

Authors:  Robert S Boyd; Rebekah Jukes-Jones; Renata Walewska; David Brown; Martin J S Dyer; Kelvin Cain
Journal:  Mol Cell Proteomics       Date:  2009-04-02       Impact factor: 5.911

6.  Hairy cell leukemia-related disorders consistently show low CD27 expression.

Authors:  Yoko Hashimoto; Norifumi Tsukamoto; Hirotaka Nakahashi; Akihiko Yokohama; Takayuki Saitoh; Hiroshi Handa; Takafumi Matsushima; Hirokazu Murakami; Yoshihisa Nojima; Masamitsu Karasawa
Journal:  Pathol Oncol Res       Date:  2009-03-20       Impact factor: 3.201

7.  CD27 expression and its association with clinical outcome in children and adults with pro-B acute lymphoblastic leukemia.

Authors:  D Chen; N Gerasimčik; A Camponeschi; Y Tan; Q Wu; S Brynjolfsson; J Zheng; J Abrahamsson; J Nordlund; G Lönnerholm; L Fogelstrand; I-L Mårtensson
Journal:  Blood Cancer J       Date:  2017-06-23       Impact factor: 11.037

8.  A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer.

Authors:  Stéphanie Durand; Killian Trillet; Arnaud Uguen; Aude Saint-Pierre; Catherine Le Jossic-Corcos; Laurent Corcos
Journal:  BMC Genomics       Date:  2017-09-30       Impact factor: 3.969

9.  Cellular origin and pathophysiology of chronic lymphocytic leukemia.

Authors:  Marc Seifert; Ludger Sellmann; Johannes Bloehdorn; Frederik Wein; Stephan Stilgenbauer; Jan Dürig; Ralf Küppers
Journal:  J Exp Med       Date:  2012-10-22       Impact factor: 14.307

Review 10.  Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma.

Authors:  Clifford M Csizmar; Stephen M Ansell
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.